Feinstein Institutes’ Daniel A. Grande Named President-Elect of the International Cartilage Regeneration & Joint Preservation Society (ICRS)
April 18 2024 - 10:00AM
Business Wire
The International Cartilage Regeneration & Joint
Preservation Society (ICRS) has named Daniel A. Grande, PhD,
assistant vice president of research services and professor of
molecular medicine and orthopedic surgery at The Feinstein
Institutes for Medical Research, its new President-Elect. Dr.
Grande will serve a two-year term, followed by an additional
two-year term as the esteemed past president on the ICRS Executive
Board.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240418363701/en/
Feinstein Institutes’ Dr. Daniel A.
Grande has been named the new president-elect of International
Cartilage Repair Society. (Credit: Feinstein Institutes)
Dr. Grande, renowned for his significant contributions to
cartilage repair and regeneration, will lead the ICRS in its
mission to advance science and education in preventing and treating
cartilage injuries. His expertise and leadership will help drive
the society's initiatives and foster new collaborations among
research professionals globally.
"For more than thirty years, I have focused my research on
cartilage repair to advance our understandings and find new
treatments for our patients,” said Dr. Grande, professor at the
Feinstein Institutes' Institute of Bioelectronic Medicine. "I am
honored and excited to serve as the President-Elect of the
International Cartilage Regeneration & Joint Preservation
Society. I look forward to working closely with the ICRS community
to further our shared goals and continue advancing the cartilage
repair and regeneration field."
Dr. Grande is a pioneer in cell-based therapies for articular
cartilage repair. His research led to the FDA-approved autologous
chondrocyte implantation, now the standard treatment for focal
cartilage defects. While initially focusing on cartilage repair,
Dr. Grande has broadened his expertise to include tissue
engineering, stem cells, biomaterials, and biomechanics, exploring
areas like the meniscus, intervertebral disc, tendon, and bone and
the emerging field of 3D bioprinting.
He has published more than 100 peer-reviewed articles in top
journals, including Nature Reviews Rheumatology and Clinical
Orthopedics, and has contributed to book chapters and editorials.
Recently, his lab pioneered 3D bioprinting applications and
collaborated with other departments on biomaterials and tracheal
reconstruction. Most recently, he published in the Journal of
Cartilage & Joint Preservation, looking at extracellular
vesicles (EVs) from mesenchymal stem cells (MSCs) believed to help
in cartilage regeneration, and helped redefine orthobiologics in
the Open Journal of Regenerative Medicine.
“Dr. Grande founded the orthopedic research lab at the Feinstein
Institutes and continues to explore innovative regenerative
therapies, including stem cells and 3D bioprinting," said Kevin J.
Tracey, MD, president and CEO of the Feinstein Institutes and
Karches Family Distinguished Chair in Medical Research. “On behalf
of our 5,000 researchers and staff, we congratulate Dr. Grande on
his election to the ICRS and look forward to his continued
leadership.”
The ICRS is a prominent international society dedicated to the
advancement of cartilage research, focusing on the prevention and
treatment of cartilage injuries. With a network of leading experts
and researchers from around the world, the society plays a pivotal
role in promoting innovative research, education, and clinical
practice in the field of cartilage repair.
About the Feinstein Institutes The Feinstein Institutes
for Medical Research is the home of the research institutes of
Northwell Health, the largest health care provider and private
employer in New York State. Encompassing 50 research labs, 3,000
clinical research studies and 5,000 researchers and staff, the
Feinstein Institutes raises the standard of medical innovation
through its five institutes of behavioral science, bioelectronic
medicine, cancer, health system science, and molecular medicine. We
make breakthroughs in genetics, oncology, brain research, mental
health, autoimmunity, and are the global scientific leader in
bioelectronic medicine – a new field of science that has the
potential to revolutionize medicine. For more information about how
we produce knowledge to cure disease, visit
http://feinstein.northwell.edu and follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240418363701/en/
Matthew Libassi 631-793-5325 mlibassi@northwell.edu